MétaCan
Menu
Back to cohort
Record W4381249225 · doi:10.1016/j.jhep.2023.04.035

A global research priority agenda to advance public health responses to fatty liver disease

2023· article· en· W4381249225 on OpenAlexaff
Henry E. Mark, Alina M. Allen, Juan Pablo Arab, Saleh A. Alqahtani, Marco Arrese, Ramón Bataller, Thomas Berg, Paul Brennan, Patrizia Burra, Graciela Castro‐Narro, Helena Cortez‐Pinto, Kenneth Cusi, Nikos Dedes, Ajay Duseja, Sven Francque, Hannes Hagström, Terry T.‐K. Huang, Dana Ivancovsky‐Wajcman, Christopher J. Kopka, Aleksander Krag, Philip N. Newsome, Mary E. Rinella, Diana Romero, Shiv Kumar Sarin, C Wendy Spearman, Emmanuel Tsochatzis, Luca Valenti, Marcela Villota‐Rivas, Shira Zelber‐Sagi, Jörn M. Schattenberg, Vincent Wai‐Sun Wong, Zobair M. Younossi, Fredrik Åberg, Leon A. Adams, Khalid Al‐Naamani, Reda Albadawy, Zinaida Alexa, Michael Allison, Faisal Abdullatif Alnaser, Khalid Alswat, Mário Reis Álvares‐da‐Silva, Domenico Alvaro, Michele Alves‐Bezerra, Raúl J. Andrade, Quentin M. Anstee, Yaw Asante Awuku, Oidov Baatarkhuu, György Baffy, Shokhista Bakieva, Meena B. Bansal, Robert Barouki, Rachel L. Batterham, Cynthia Behling, Renata Belfort‐DeAguiar, Annalisa Berzigotti, Michael Betel, Cristiana Bianco, Emanuele Bosi, Jérôme Boursier, Elizabeth M. Brunt, Elisabetta Bugianesi, Christopher J. Byrne, María Cecilia Cabrera Cabrejos, Stephen Caldwell, Rotonya M. Carr, Laurent Castéra, Maria Gabriela Castillo-López, Cyrielle Caussy, Eira Cerda‐Reyes, Antonio Ceriello, Wah‐Kheong Chan, Yoosoo Chang, Phunchai Charatcharoenwitthaya, Norberto C. Chávez‐Tapia, Raymond T. Chung, Massimo Colombo, Kirsten J. Coppell, Helma Pinchemel Cotrim, Antonio Craxı̀, Javier Crespo, Anuradha Supun Dassanayake, Nicholas O. Davidson, Robert J. de Knegt, Victor de Lédinghen, Münevver Demir, Hailemichael Desalegn, M. Diago, John Dillon, Bruce Dimmig, M. Ashworth Dirac, Melisa Dirchwolf, Jean‐François Dufour, Karel Dvořák, Mattias Ekstedt, Mohamed El‐Kassas, Osama Mohamed Elsanousi, Ahmed M. Elsharkawy, Reda Elwakil, Wayne Eskridge, Mohammed Eslam, Gamal Esmat, Jian‐Gao Fan, Maria Lúcia Gomes Ferraz, Robert Flisiak, Davide Fortin, Yasser Fouad, S L Freĭdman, Michael Fuchs, Adrián Gadano, Amalia Gastaldelli, Anja Geerts, Andreas Geier, Jacob George, Lynn H. Gerber, Hasmik Ghazinyan, Liana Gheorghe, Denise Giangola Kile, Marcos Girala, Nicolas Goossens, Isabel Graupera, Henning Grønbæk, Saeed Hamid, Vanessa Hebditch, Zachary Henry, Ingrid J. Hickman, L. Ansley Hobbs, Samantha Hocking, Wolf Peter Hofmann, Ramazan Idılman, Paula Iruzubieta, Scott Isaacs, Isakov Va, Mona Ismail, Mohammad H. Jamal, Helen Jarvis, Peter Jepsen, François R. Jornayvaz, K. C. Sudhamshu, Satoru Kakizaki, Saul J. Karpen, Takumi Kawaguchi, Shelley E. Keating, Yousef Khader, Seung Up Kim, Won Kim, David E. Kleiner, Ger H. Koek, Narcisse Komas, Loreta A. Kondili, Bart G.P. Koot, Marko Korenjak, Eleni Kotsiliti, Yiannoula Koulla, Carina Kugelmas, Marcelo Kugelmas, Asma Labidi, Naomi F. Lange, Joel E. Lavine, Mariana Lazo, Nathalie C. Leite, Han‐Chieh Lin, Undram Lkhagvaa, Michelle T. Long, Patricio López‐Jaramillo, Adelina Lozano, Maria Paula Macedo, Reza Malekzadeh, Giulio Marchesini, Sebastián Marciano, Kim Martínez, S Vázquez, Lyudmila Mateva, José M. Mato, Charles Mbendi Nlombi, Alexis Gorden McCary, Jeff McIntyre, Martin McKee, Juan Manuel Mendive, Ivana Mikolašević, Pamela S. Miller, Terri Milton, R. Moreno-Alcántar, Timothy R. Morgan, Ayesha A. Motala, Jean Muris, Carla Musso, Edna J. Nava‐González, Francesco Negro, Alexander Nersesov, Brent A. Neuschwander‐Tetri, Dafina Nikolova, Suzanne Norris, Katja Novak, Ponsiano Ocama, Janus P. Ong, Arlinking Ong-Go, Charles Onyekwere, Martín Padilla, Raluca Pais, Calvin Q. Pan, Arturo Panduro, Manas Kumar Panigrahi, Imran Paruk, Keyur Patel, Carlos Penha‐Gonçalves, Marlene Pérez Figueroa, Juanita Pérez-Escobar, Juan M. Pericàs, Gianluca Perseghin, Mário Guimarães Pessôa, Salvatore Petta, Cláudia P. Oliveira, Dorairaj Prabhakaran, Nikolaos Pyrsopoulous, Atoosa Rabiee, Alnoor Ramji, Vlad Ratziu, Natarajan Ravendhran, Katrina Ray, Michael Roden, Stefano Romeo, Manuel Romero‐Gómez, Yaron Rotman, Samir Rouabhia, Ian Rowe, Shakhlo Sadirova, Maryam Alkhatry, Riina Salupere, Sanjaya K. Satapathy, Jeffrey B. Schwimmer, Giada Sebastiani, Lynn Seim, Yosuke Seki, Abdel Karim Sermé, Д. А. Шапиро, Lali Sharvadze, Jonathan E. Shaw, Isaac Thom Shawa, Oren Shibolet, Yusuke Shimakawa, Jay H. Shubrook, Shivaram Prasad Singh, Edford Sinkala, Ľubomír Skladaný, Ігор Миколайович Скрипник, Myeong Jun Song, Silvia Sookoian, Kannan Sridharan, Norbert Stefan, Jonathan G. Stine, Dhastagir Sultan Sheriff, Shikha S. Sundaram, Gianluca Svegliati‐Baroni, Mark G. Swain, Frank Tacke, Shahrad Taheri, Soek-Siam Tan, Elliot B. Tapper, Giovanni Targher, Eugen Tcaciuc, Maja Thiele, Dina Tiniakos, Ieva Tolmane, Aldo Torre, Esther A. Torres, Sombat Treeprasertsuk, Michael I. Trenell, Svetlana Turcan, Adela Turcanu, Jonas Valantinas, Laurens A. van Kleef, J.A. Velarde-Ruiz Velasco, Mette Vesterhus, Eduardo Vilar‐Gómez, Imam Waked, Julia Wattacheril, Heiner Wedemeyer, Fonda Wilkins, José Willemse, Robert J. Wong, Yusuf Yılmaz, Hannele Yki‐Järvinen, Ming‐Lung Yu, Volkan Yumuk, Müjdat Zeybel, Kenneth I. Zheng, Ming‐Hua Zheng

Bibliographic record

VenueJournal of Hepatology · 2023
Typearticle
Languageen
FieldMedicine
TopicLiver Disease Diagnosis and Treatment
Canadian institutionsLondon Health Sciences CentreWestern University
FundersNovartis PharmaCenters for Disease Control and PreventionNorgineLG ChemIpsenSun PharmaUnited European GastroenterologyNovo Nordisk FondenEuropean Association for the Study of the LiverSyddansk UniversitetArrowhead PharmaceuticalsDanmarks GrundforskningsfondNational Research FoundationEuropean Association for the Study of DiabetesNovo NordiskNational Institute for Health and Care ResearchEuropean Foundation for the Study of DiabetesIntercept PharmaceuticalsAstraZenecaBarts CharityRegeneron PharmaceuticalsGilead SciencesMedical Research CouncilEA Pharma Co., Ltd.InnovationsfondenInventiva PharmaPfizerAmerican Association for the Study of Liver DiseasesGlaxoSmithKlineNational Institute of Diabetes and Digestive and Kidney DiseasesSanofiEli Lilly and Company
KeywordsPublic healthFatty liverEnvironmental healthDiseasePolitical scienceBusinessMedicineInternal medicinePathology

Abstract

fetched live from OpenAlex

BACKGROUND & AIMS: An estimated 38% of adults worldwide have non-alcoholic fatty liver disease (NAFLD). From individual impacts to widespread public health and economic consequences, the implications of this disease are profound. This study aimed to develop an aligned, prioritised fatty liver disease research agenda for the global health community. METHODS: Nine co-chairs drafted initial research priorities, subsequently reviewed by 40 core authors and debated during a three-day in-person meeting. Following a Delphi methodology, over two rounds, a large panel (R1 n = 344, R2 n = 288) reviewed the priorities, via Qualtrics XM, indicating agreement using a four-point Likert-scale and providing written feedback. The core group revised the draft priorities between rounds. In R2, panellists also ranked the priorities within six domains: epidemiology, models of care, treatment and care, education and awareness, patient and community perspectives, and leadership and public health policy. RESULTS: The consensus-built fatty liver disease research agenda encompasses 28 priorities. The mean percentage of 'agree' responses increased from 78.3 in R1 to 81.1 in R2. Five priorities received unanimous combined agreement ('agree' + 'somewhat agree'); the remaining 23 priorities had >90% combined agreement. While all but one of the priorities exhibited at least a super-majority of agreement (>66.7% 'agree'), 13 priorities had <80% 'agree', with greater reliance on 'somewhat agree' to achieve >90% combined agreement. CONCLUSIONS: Adopting this multidisciplinary consensus-built research priorities agenda can deliver a step-change in addressing fatty liver disease, mitigating against its individual and societal harms and proactively altering its natural history through prevention, identification, treatment, and care. This agenda should catalyse the global health community's efforts to advance and accelerate responses to this widespread and fast-growing public health threat. IMPACT AND IMPLICATIONS: An estimated 38% of adults and 13% of children and adolescents worldwide have fatty liver disease, making it the most prevalent liver disease in history. Despite substantial scientific progress in the past three decades, the burden continues to grow, with an urgent need to advance understanding of how to prevent, manage, and treat the disease. Through a global consensus process, a multidisciplinary group agreed on 28 research priorities covering a broad range of themes, from disease burden, treatment, and health system responses to awareness and policy. The findings have relevance for clinical and non-clinical researchers as well as funders working on fatty liver disease and non-communicable diseases more broadly, setting out a prioritised, ranked research agenda for turning the tide on this fast-growing public health threat.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.088
Threshold uncertainty score0.461

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.176
GPT teacher head0.464
Teacher spread0.288 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations132
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueJournal of HepatologySame topicLiver Disease Diagnosis and TreatmentFrench-language works237,207